drugset / Trial / NCT02865642
Cortical Ischemic Stroke and Serotonin
Phase 2
Unknown
90 enrolled
Insel Gruppe AG, University Hospital Bern
Cantonal Hospital of St. Gallen · collab
RandomizedParallel-groupQuadruple-blindSupportive care
Summary
In this study the investigators want to test the hypotheses that, serotonergic neuromodulation increases perilesional neuroplasticity, leading to improved behavioural outcomes through a more efficient allocation of functional resources, greater structural reorganization and less remapping via alternative circuits.
Timeline
- Start
- 2016-08
- Primary completion
- 2020-09
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 20 mg | — |